SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: james who wrote (1324)12/2/1997 11:13:00 AM
From: Biomaven  Read Replies (1) | Respond to of 4676
 
james:

<<But diagnostics will be more profitable at this stage. Just 'gut-feeling'>>

Well I _paid_ for my lesson that innovative cancer diagnostics and "profitable" don't belong in the same sentence with my (fortunately small) investment in Matritech (NMPS). You can have the lesson for free <G>.

New cancer diagnostics seem hard to market - nasty issues like insurance re-imbursability lurk in the background. There are obvious pressures to cover new cancer treatments, new diagnostics are much tougher.

Peter